Non-invasive grading of primary brain tumours: Results of a comparative study between SPET with 123I-α-methyl tyrosine and PET with 18F-deoxyglucose

European Journal of Nuclear Medicine

Volumn 24, Issue 4, 1997, Pages 428-434

  Woesler, Burkhard ^a   Kuwert, Torsten ^a   Morgenroth, Carlo ^a   Matheja, Peter ^a   Palkovic, Stefan ^a   Schäfers, Michael ^a   Vollet, Bernhard ^a   Schäfers, Klaus ^a   Lerch, Hartmut ^a   Brandau, Wolfgang ^a   Samnick, Samuel ^a   Wassmann, Hansdetlef ^a   Schober, Otmar ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Brain neoplasms; Fluorine 18 fluorodeoxyglucose; Iodine 123 methyl tyrosine; Positron emission tomography; Single photon emission tomography

Indexed keywords

AMINO ACID; FLUORODEOXYGLUCOSE F 18; IODINE 123; METIROSINE;

ADULT; AGED; AMINO ACID TRANSPORT; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; GLIOMA; GLUCOSE METABOLISM; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MALE; PERCEPTIVE DISCRIMINATION; POSITRON EMISSION TOMOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 8244243238     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00881816     Document Type: Article

References (46)

1. Schmidek HH. Surgical management of supratentorial gliomas. In: Schmidek HH, Sweet WH, eds. Operative neurosurgical techniques, 3rd edn. Philadelphia: Saunders; 1995: 517-534.
2. Glantz MJ, Burger PC, Herndon JE, Friedman AH, Cairncross JG, Vick NA, Schold SC. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 1991; 41: 1741-1744.
3. 18F]fluorodeoxyglucose in brain tumours: a powerful diagnostic and prognostic tool. Invest Radiol 1986; 22: 360-371.
4. Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, Larson SM. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985; 62: 816-822.
5. Hölzer T, Herholz K, Jeske J, Heiss WD. FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. J Comput Assist Tomogr 1993; 17: 681-687.
6. Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M. Positron emission tomography in patients with glioma - a predictor of prognosis. Cancer 1988; 62: 1074-1078.
7. Kim CK, Alavi JB, Alavi A, Reivich M. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neurooncol 1991; 10: 85-91.
8. Mineura K, Sasajima T, Kowada M, Ogawa T, Hatazawa J, Shishido F, Uemura K. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 1994; 73: 2386-2394.
9. Schifter T, Hoffman JM, Hanson MW, Boyko OB, Beam C, Paine S, Schold SC, Burger PC, Coleman RE. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumours. J Comput Assist Tomogr 1993; 17: 509-516.
10. Kuwert T, Morgenroth C, Woesler B, Matheja P, Palkovic S, Vollet B, Samnick S, Maasjosthusmann U, Lerch H, Gildehaus F-J, Wassmann H, Schober O. Uptake of iodine-123-α-methyl tyrosine by primary brain tumours and non-neoplastic brain lesions. Eur J Nucl Med 1996; 23: 1345-1353.
11. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. Berlin, Heidelberg, New York: Springer, 1993.
12. Kuwert T, Morgenroth C, Woesler B, Matheja P, Palkovic S, Vollet B, Schäfers M, Wassmann H, Schober O. Influence of size of regions of interest on the measurement of uptake of iodine-123-α-methyl tyrosine by brain tumours. Nucl Med Commun 1996; 17: 609-615.
13. 3, a reagent for iodination with high specific activity. Radioclin Acta 1977; 24: 42-46.
14. Fischer S, Wolf H, Brandau W, Clausen M, Henze E, Schober O. Iodierung von α-Methyltyrosin (AMT): Optimierung der Methode für die Routinepräparation. Nucl Med 1993; 32: A113.
15. Kuikka JT, Tenhunen-Eskelinen M, Jurvelin J, Kiliänen H. Physical performance of the Siemens Multi SPECT 3 gamma camera. Nucl Med Commun 1993; 14: 490-497.
16. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; NS-26/2: 2780-2789.
17. Wienhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U, Heiss WD. Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr 1992; 16: 804-813.
18. Talairach J, Tournoux P. Co-planar stereotactic atlas of the human brain. Stuttgart, New York: Thieme; 1988; 37-110.
19. 11C-methionine for diagnosis of recurrent brain tumors and radiation injury. Acta Radiol 1991; 32: 197-202.
20. Bortz J. Lehrbuch der Statistik, 2nd edn. Berlin, Heidelberg, New York: Springer, 1985.
21. Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, Kessler RM. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 1995; 195: 47-52.
22. Metz CE. ROC methodology in radiologic imaging. Invest Radiol 1986; 21: 720-733.
23. Metz CE. Quantification of failure to demonstrate statistical significance. Invest Radiol 1993; 28: 59-63.
24. Müller SP, Reiners C. Untersuchungen und Empfehlungen zum Design von ROC-Studien in der Nuklearmedizin. Nucl Med 1995; 34: 24-31.
25. Herholz K, Friedrichs B, Jeske J, Heiss WD. Prognostic significance of positron emission tomography with F-18-fluorodeoxyglucose in gliomas. J Cancer Res Clin Oncol (Suppl) 1992; R119.
26. Patronas NJ, Di Chiro G, Brooks RA, DeLaPaz RL, Kornblith PL, Smith BH, Rizzoli HV, Kessler RM, Manning RG, Channing M, Wolf AP, O'Connor CM. 18-Fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 1982; 144: 885-889.
27. 18F]fluorodeoxyglucose positron emission tomography. Ann Neurol 1991; 29: 347-355.
28. Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP. Glucose utilization of cerebral gliomas measured by 18-F-fluorodeoxyglucose and positron emission tomography. Neurology 1982; 32: 1323-1329.
29. Patronas NJ, Brooks RA, DeLaPaz RL, Smith BH, Kornblith PI, Di Chiro G. Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas. AJNR 1983; 4: 533-535.
30. 11C]L-methionine uptake in gliomas. Neursurgery 1989; 25: 720-728.
31. 18F)fluorotyrosine. J Nucl Med 1991; 32: 1338-1346.
32. Schober O, Meyer GJ, Stolke D, Hundeshagen H. Brain tumor imaging using C-11-labelled L-methionine and D-methionine. J Nucl Med 1985; 26: 98-99.
33. 11C)-methionine in brain tumors studied with positron emission tomography. Acta Radiol 1987; 28: 225-229.
34. Ishiwata K, Kubota K, Murakami M, Kubota R, Sasaki T, Ishii S, Senda M. Re-evuluation of amino acid PET studies: Can the protein synthesis rates in brain and tumor tissues be measured in vivo? J Nucl Med 1993; 34: 1936-1943.
35. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, Shimosegawa E, Ito H, Hatazawa J, Okudera T, Uemura K, Yasui N, Mineura K. Cerebral glioma: evaluation with methionine PET. Radiology 1993; 186: 45-53.
36. 11C-methionine. AJNR 1996; 17: 345-353.
37. Drane WE, Abbott FD, Nicole MW, Mastin ST, Kuperus JH. Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress. Radiology 1994; 191: 461-465.
38. 123I]iodomethyl tyrosine: competition with natural L-amino acids. J Nucl Med 1991; 32 1225-1228.
39. 124IMT and first clinical results. J Nucl Med 1990; 31: 281-286.
40. Kawai K, Fujibayashi Y, Saji H, Konishi J, Yokoyama A. New radioiodinated radiopharmaceutical for cerebral amino acid transport studies: 3-iodo-alpha-methyl-L-tyrosine [abstract]. J Nucl Med 1988; 29: 778.
41. 123I-iodo-α-methyltyrosine uptake in brain tumor recurrences. Nucl Med 1995; 34: 71-75.
42. 123I]iodo-α-methyl tyrosine and SPECT. J Nucl Med 1989; 30: 110-112.
43. Kuwert T, Sures T, Herzog H, Loken M, Hennerici M, Langen KJ, Feinendegen LE. On the influence of spatial resolution and of the size and form of regions of interest on the measurement of regional cerebral metabolic rates by positron emission tomography. J Neural Transm (Suppl) 1992; 37: 53-66.
44. Leskinen-Kallio S, Ruotsalainen U, Nagren K, Teräs M, Joensuu H. Uptake of caron-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. J Nucl Med 1991; 32: 1211-1218.
45. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-301 SPECT to quantitative malignancy grade of gliomas. J Neurosurg 1989; 71: 342-346.
46. Oriuchi N, Tomiyoshi K, Inoue T, Ahmad K, Sarwar M, Tokunaga M, Suzuki H, Watanabe N, Hirano T, Horikoshi S, Shibasaki T, Tamura M, Endo K. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. J Nucl Med 1996; 37: 457-462.